Krishna Institute of Medical Sciences Limited

🔴 Bear CaseWhat could go wrong?

1. Margins are being competed away
   EBITDA margin has fallen from 28.8% to 21.3%. If the trend continues, profit falls even on flat sales — and margin decline rarely reverses quickly.
2. The debt load needs earnings to hold up
   Debt is 5.2x EBITDA. At that level a downturn in earnings turns a manageable balance sheet into a refinancing problem, and lenders get paid before shareholders.
3. Sales are being booked faster than collected
   Receivables are up 119% against revenue up 79%. If customers keep taking longer to pay, reported profit will not turn into cash — and write-offs follow if some never do.
4. The price already assumes success
   The stock trades 87% above its own median multiple. At this level the business has to deliver just to stand still, and a stumble is repriced twice — lower earnings on a lower multiple.
5. Returns on shareholder capital are falling
   ROE has dropped from 20.1% to 10.7%. Each rupee of equity earns less than it did, so profit growth increasingly depends on raising more capital rather than on the existing base working harder.